Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Wolfe Laboratories, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Wolfe Laboratories, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roger Rush, Ph.D. has been named vice president of preclinical development, Wolfe Laboratories. Dr. Rush has more than 25 years of international experience in pharmaceutical R&D with a focus on preclinical research, development, and program management, particularly in the transition of discovery research candidates to clinical development.
   
“We’re delighted to have Dr. Rush as part of our team,” said Janet Wolfe, Ph.D, president of WLI. “His wealth of experience will be a tremendous asset to the company. He will play a critical role in the company as we expand our services and continue to provide clients with the highest quality preclinical services in a timely manner.”
   
Prior to joining the company, Dr. Rush held a number of positions of increasing responsibility with pharmaceutical and biotechnology companies, including department head of drug metabolism at Syntex Research in Europe, and vice president of preclinical sciences at Roche Pharmaceuticals, which involved responsibility for the functions of drug metabolism and pharmacokinetics, toxicology and pathology, and pharmaceutical development. Throughout his career he has contributed to the approval of numerous INDs, CTAs, NDAs and MAA drug registration dossiers.
   
Dr. Rush participated in the transition of the Syntex Research Centre in Edinburgh into Quintiles Transnational and established that facility as a provider of pharmaceutical R&D services. In his role as business development director he was responsible for the sales and marketing of Quintiles’ preclinical services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics